{
    "nanoparticle_formulation": "J-1-8Br-cAMP hydrogel",
    "nanoparticle_type": "antimicrobial peptide",
    "lipid_cholesterol_ratio": "None",
    "particle_size_mean_nm": "None",
    "particle_size_std_nm": "None",
    "particle_charge_zeta_potential_mean_mV": "None",
    "particle_charge_zeta_potential_std_mV": "None",
    "surface_modification": "None",
    "surface_modification_elaboration": "None",
    "peg_type": "None",
    "disease": "diabetic wounds",
    "intended_targeted_site_of_the_nanoparticle_drug": "wound tissue",
    "payloads": "Jelleine-1, 8-Bromoadenosine-3', 5'-cyclic monophosphate",
    "drug_molecular_weight": "953.57 Da",
    "toxicity": "Low",
    "gene_length": "None",
    "injected_in_vivo_drug_concentration": "None",
    "loading_efficiency": "None",
    "half_life": "None",
    "dose_frequencies": "None",
    "drug_blood_concentration": "None",
    "animal_model": "MRSA infected diabetic wound model in rats",
    "animal_species": "Kunming mice and Sprague-Dawley (SD) rats",
    "animal_age": "18-22 g for mice and 180-200 g for rats",
    "animal_sex": "male",
    "nanoparticle_drug_administration_routes": "subcutaneous tissue",
    "pk_pd_pharmacokinetics_pharmacodynamics": "None",
    "clinical_trial_with_human_subject": "None",
    "clinical_trial_side_effect": "None",
    "drug_stability_in_vivo_stability": "True",
    "storage_condition": "The hydrogel was stored at 37 \u00b0C in a carbon dioxide cell incubator.",
    "biodegradability": "True"
}